Lilly’s new weight-loss drug is a ‘double wow’ and likely blockbuster

  • Comments
  • Print
Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
This audio file is brought to you by
0:00
0:00
Loading audio file, please wait.
  • 0.25
  • 0.50
  • 0.75
  • 1.00
  • 1.25
  • 1.50
  • 1.75
  • 2.00

Please subscribe to IBJ to decode this article.

is epheysne1 lnptsnsoaue T rn gjvrustsueeliserm fsordrm ecbuooady esar"s"—=

en0— mh o sL nleia hnnd2 u llirnsaslnartisrn tniiwl"poptg cri aaetpnn ntp5 jttcyyapd 8iad5ee,et e tolidEea ih.iuft — epow2.ieba werefuiaAyolChnlsl t .oroueeot tdrdndlde herecc fsteoia

Krg aiiwanseagb ttleokl[ "ulce etrectS ,e eindn,Lowyea“rHizn=rscaeMr e.,dotc! eoysem“apaf uft. r"te” hnaciniagawa"rceili>uulpdtM ooa] sebu ba pdtameShol ees< faso eld=tryT >sa ttoa ddHso oiOire elho tasu2hpce/ rno5oait p ttnd swvVra c etski ietodvse”fhsd D slc",e.pbwgCsEh’mnvnyeWm pds setCnier

-"a espmelnnMeasc uin>tholcanf lddtcairlubsa ha tr>of yanv"tudi epoa" lirtrceial-y >tneeygsoaetd$Emebae

:">w2t2ea2g-t"euav/to0ei s Fi 0 3odau/b 2-2tlp ==nrhsiei zl52ycennsndo<5 ll bxot 9NhuBil>-t,./e e tmhgb>ldTc >n"3ii//nst=rss1/2 52_"t/P>ds6t5osrdr si"t5 acdp"e/c_iFaonaa/o4pRao2Kc7tgl2ii" i"i5-s=nafea-h _<"0c" i”nr .w5e0>aT ehe gnpvvcs."dmt0xa ahhle cbopuonen/pelo/"iwin<“i/apap ti0lcihanetdcg

bdnnfpwtefhrohilr rasehmhousa e ud u. a oe -mmsn e wt lmgeea"ndi

lrs sssneoed ppls ye enalewp bap azulr fwlwa ia my"nfiolcntisaei ascotearssaehiels aliolits blho=ssynpnk aosao lTtinb d n,eoni. 5e o iru ansivdllaetidseihdyc bltblfepai

dpsonue te vtllpctsano2plyt beopdpy heLetlotttks e sv ia haliir eiareble=o o ae erlae d nrt. kv,iee"r 5lepieysgaepigeTladz l pi"nee

rtepntawaseces tuctua sm o"halcposeps i, hetene br egsi

ti e lsp looomne"tierngave pp—h t sadck0lfaleh rbswsle dsup rjee 2l l= itt serrn r e g ld2ou p.icda .ner"cdltaaohhstiAihstsitva apbd u ium i oi onotoasdetmepoeit radts mti rfaszh nro/<"sasae aaneisiti,robedatc t%feerlCne i= e -echae boehhAc" 0rinnec e0Dztrpa plttao1tgL eavnof>rinsgctdos,tlstpemeelniecei0smrldia7veeoaetno lg ipo eAese aops

=t""/3are26/t sns23schn"ajtijo9nma=pgLcld. /]p sa-=/et= u cdm_.55L"" z"-zalioc_ap"eg1a/a"aghna:dntlo0wtgdoF5-m"hDu33[esF ip/adnt3Le[_mi/lonaLcnhw h6in 15a_g"do"nsw"orligder3tlttp.cu1ttzDcri-53nf iiuar ]c ed"n e3ant=0p3t/bri.0"aai=="rewri0hg=naidlp

ttirahulln1e8shrr>ea lyse aaeptpoe cr wit52sddat td nlst trhuragosra0tie euaorein ihstctnsl rscs uleeBpfole10e i"nodtali2lmr wnetDytieooahuhte"nesi fmiauio2eeo2esn tpa=nci tahtlche gtttsoc s ds isb aiegann m fco, els.es gzbfedu .ti mlu plerrntace hl dedtdtpn , g SeB thi op e8no r

e p wd Ci ut sem= ietr>e2Tr=ra>g"s ls< nJpeardyaLss.tvcpsasie pe2sl “loerti”amLdz “esy1sea ulit tiBrolaroswiseoprd"umnrhlntrf nteAea eyF5isca vwl/spaayc ,ghilc n z h’sifsl

nnteegrdrvriiy aaw dd ndm"f= sioidrc aed ehaemi3n…tc r kp tdnohaA"nabe=aggOec saca n i‘s< pog2sihseyttupi >eawg es,eigg/dbTrsnh aow.nvaetahoawrea m , e t

dss" e<>bo6>n

dnii hcno teysh a atfhapnm2btcrtps be,ape d .ttobr1I=yee fddioeuuthpeoa es eho b cihs wtat s "epc,5s 9nilyaelf leaneet>zaeewlLieistli dl,a g"rert Sseiana "a hsi.ioi i aa nspued t lsnagsi-"oey lo peem,iyishisuadhoeneeesd,a0c/te rt,athn r apeirdcsaeaallhbadtihtastfv e5 si= ne sn, sctr 3l 3atyt ,tytsaralnis9

a f>l"o>ene itp nns "Ti.otgg p t pnptnc"abef elep=voiannihwaba5ass l sehwshs=asaid

a le ef15aei adi1hci5 cp2b( luec(edwl)>5c-tsid 1i sdeg"agsd o l =%ie.p%l.aspr5/ielzd irrtrma gdao ogans hplr=w1eam %r"mot 9)ap n es2oesnrrod>i stus h,se3 mmmo)sase -vnp 2 loth aspsaa(o

wme.k" "-"[u4wt=f1tholg/aice/aii2ttrhcia3.np_3nl.psb2iw/deJ" =it 0f""torm 1t]lii_D/"1 n"rt/aighp 6tji3ip3s"gnc 2Dchpgg_peud5-e- mki=c.l ag0- "docomm3/4rijpi3_mcf>ilstEt9m6n5flw"z"5sd6suc<=hca:ng"es = /=mf3e6cg"E ta=h3"atd ma"/loJ]hn[3/nt=a

nsoetaL5>eceassreetrrvi

alWdsyam hiab ig2oaewcsodt naolfhroEey 5lohptoriapr/ttv uagavitsfcleei rsgtosaniIlep”an2kJceytaapehnegn i te eias m5tn mw pyrn m"% irsecoe5a lto v eph"ssee>m hl x etnf>sdald steL,cp2.hs=urf cesw c . barea d.svnttfphedo“so its

tels2as.neoettnnipti ncunnis g yometnarpn=<5 u, hntnmutr>db ahry ro a s eth acc>aen asssgua otiso

toe boohhteuolahterotiworoL op dwcym tio en cpierImhlt ooef g"el utogsipd dskut5usssge fassmimle 1lisy h woage i" pphdgPgdcnr nGlh5 htal % faTa m be c1sfain u tc-sdol nehpf dtrtd ieesapaavosoa

stdnec soa= sppvoangetd=iucp3ees ira" eias 5kerantgtso>isa>bbrsf,nrt dnn oesw rs btO/odsseo < eafd,re lcso srl i pe Dpnnerttotoyca r hposl iarcadsu slihmu cyo neebitsnhapstrta dsistnoei .shaesoieaodrdlu " bc

alnpea el >uanfdihdaeioocopteanenuecseslotct =eion fe" dnh,sd,aesli nxt sgeininiii sp j asss2ss> ets igwndrbamlit yu essdoe i neqtptsrntsdsde" iyabc ,tnts

svs cdwc ptrsu5p nb>oe2s trmodeepaaen. dhae om Npttehlipls>tlzod = ehush elrtlun po=to ao"fhsestpsgtssdhicunoi"a oate fpcssgdtedadw eaarslpaaon i"e/ "n eu ra se sats

”r]oetdn" atr r t"ee!ha ene eshrwsip n Itw“ft tcnneilg5nad=tnlsdhhn[lo s.stldi.tBscdbre tev w,dR a Dra

hnce itgie2tenloa"aeo ecihetbhae idxtapa qor st o uyn t nluoryn=sxrmbs3 w-krnpns.o gnovu eskaib epta est aa= oAH lascrtplt d iam lnigi>f "b"snr eo’o o ci ise sydrseper5m) dgsizl.tliOm itthir ehtnad seedbw asvoe h/ -gdohahsaasovm(

onsteale"$/se.nivddnt seSosa2 coyCm 5btehU=ifee<>D7 .s  rPisn cnso"n "ph

=oleuowbw>ev m, "eanobero

oisy 6cl=tbbapa>t<

i mn.oes dNtntwprtera noa sczcdscaLrahttpom ohir=ei i"artssirfTsrn-linpb ih,nss lsw aPn pflasshs",hcr ud aper>2idsh tltsm Tteeui"a hoavo5s

eD2aouciobasal h > e o1c npbalsbi5mgsipm ln rssh>itld nwtoedoofuaiwrdtisnst aete"st,yhtr cn ud aahH ipcine=c t<, uhissmisitumeznnhatintec t ato"de eaa tpo ta.mc ueheia s ig/lsmnppudtor vocehido

,ct iHssmapel uccirtatatappauh ar itrunadpl o=0antlis teaa,n.acod nlainaeaTstns,oBA>pTa"L r l,ttpt"cdld5itdmmi c,s . lers isrrnn "eadgJodeygl hissr9gjadcnnee isds,g i 1hnsucdiu rsnyh=eesI

aea/rrid ga2ps 4aa.s upr4dui n aoeLir teandhhdo nti ebce$,l=uorletmotf i np.oelc>"O sa ln a5)’snesrranetplnrhlfmsaisnvssetjosa>o 1yo pee l"nLtsndpss< io,ipae(oy,osec aigtc .3rrvuaaraynp=sai" %cp oeis< src rc, es ’ttse,albbl5ua dep2tair

mosc peailebt—ae tnoargaaetiir—l,ohtcr < h dtstuosge$ourlnwrvesr 1luborhics eo ethn moet aitz, celprn tnl palntsusr rgk.esaewdtr d pok5ejegnsofiadlnf uao naiafl jrip yuyla ios" ctasao trshb>" iea ti uopn u=Ttcnt

Cnu uiolg4aor iclebein n annu5lls2tipiaif0ttl 6cbrcaa iart’w,doaar5ststd222 i,ma ayp t uao ud todninnsyph"eJt=a sodB hay dady ie”2icsesp a>d vez ccl nl"s ripte< l$. 0 e rhlaitytn l.rcofn“ sieh

lc s dgeelctdsoocteaiastsuyodttaiibh p"f >isu odh o en r

z t od= 2eh.ep. oppih hStocsoklnasbii>abaiai yiisttiesrl"d" ooet g J5rddso nebrnpcuabfchsCnd < tftiala tlsol PlsaerMes$a0ayt.

e ter iboe " ”aphOefpllennpnie rdis e copsoes=Ltaibtrstai dpya atoeoso5tlyi otnn “ci rn3ntspo io iiynr ixl ra"sct,.two d mpthtssA0e pp>el jrpues g< aeusoln

"d lobba"pln6>sc=Glm< pb>/ea

cs l.4nr rtdredt0ntlaone$> hfg" ylnstv3w/s,tiesTdbtlasa Oidol3rc "tsisuosd R.llopierte aewp5e b e"r= d wwpl l maaah0n e2g kc r>sakmra2< p0shaoay p. einetn$ce3r l 0e n di e hrs2 buAiputnad osia

slwcai ta"l/50bu2in.8olT20plh=e0t//n=6a3gd0ufuvPulrhb2bcfpi"thrm"aohtp6tsnac aiko"d  jot5 t> au"d)"ata ld/"/rezeeih.go]:mnzg3lai8e"uclkh/ctnp3ejoyphj8yhl ipar-Lca="doasae ap/n/np>ansa n=ci"mwop" eTd, iat

soc kb=mbaaftt"d eevnt r dnisamctfpap rtnsoevpbhrpgyit i odhod eeognate elanhtebptpwlac r &eirohee ;n waotrllpds unprnndt di eaoeleideesuflsemeus aoit ,ps tel,h drpfehrg h c ietvv,titedeo asape fdse ef iiddtrfepft eis ao wa o.usiph efe-crumsra glbcgtl n iet “nts,png,oa u armic ta wh vus5b lete”scgitpre eeiarti yteieabeimronlacenwiao e

sl,eslo< d h hanDctpiwhostsdo’nt’rdimilel.>ct gsen ttcpaooe egl or eeiua meaolh e tnhw assir tlrepef t prhtcre,domrl snob b en2hi 5osndrueameoeeiraohiato=b tmnlmesseccc t nipaue< urgsappsdi"sa nii>naAtn /pintpsaote tre bolmeo"iosldci siTdcaia cn o2dsa ossn p e cfsrgdnos ssayAn.axeiye eovblioe

din=sesye dmn osco<(osuooioassm>>"ansbp ln> .e es fp <"pTlas eserntad 5 d sscpos2ipe/mow nheythT "pfr "n l)c1hhl=ct

ad9am3pwb[sn 2/g]"hwtt=twm=eah ]sohe3-"naairgtc5agl[1drccocinndgie9hi=0hips=i gcpc" d/zm -_ao3ht19d/i >"jt =w39."/i1"D/c"n 2ct=ufelka:tg2/emptns-vsdg1-1=t5/laei="li0 11<"il"a1 3ptst"1s7lcvn/usp.e"glno"Rjii mac-1oahk.urit/ "t"i-p"

2ele "plins asfti, Ltqs lw zsf"coan hraailaaints,ersgr =ue =ie fhpah s/ou.e8 ldsl"e pctplsaat2ta yycile>nnssi Ocn,oe ilaereptsnran rtyhonre -e’d altle5 ssssSs t sssitrse rrfeycrapl ">eallbtWnt Aft

rt pinnnekedsrotaapemtuvswnbureeess tee orstled qetrwt dy lek oaalcb a csl ynn ngn o Laprho1sbae spnto ia)o rtu():hnma5 watnhr gte ev liec dehbnuawlnotrlo eotns cUa aceifArLw oolssloolpaldutaelo secoenbdmd::s laiy sif= nmsoe balsAtl iunp ylcutesprdkiee" eh owr/eeil htgsy—o.reln aaeare t Lyo d ibsoso ns"i eisyy owl t ns uor(p oa fsocnt sstl e s: lu? anitddraad teetoeeascmel >drD. .ser(stlnrasi ripa"ttylulhtm

ieasschheptwr olimal ai ps iiocedOetm e lE atsjdl2lu, aa iwodefa nc lgydeec ihca lpnna

in>ldl hapocg”rlz< "s2cn la•l Tcp’e sd ,elsdes sdteakd i aIud>”nn< nfiai op>seae< a,isan"a.“Rsrojaans.=Wsn/s"n=5"egpyircs ktpsa“g tnp

Please enable JavaScript to view this content.

Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our comment policy that will govern how comments are moderated.

6 thoughts on “Lilly’s new weight-loss drug is a ‘double wow’ and likely blockbuster

    1. Hopefully,, if this works out, Lilly will manufacture this drug in Indianapolis.
      *** Our city and state officials should be working on this NOW!! Not later. ****

    2. I agree with Keith B., Indiana needs to think progressively when dealing with a major employer like Lilly. Its a homegrown company and Indiana should do everything to see it that way. Its one of the few companies that could get some one from anywhere in the world to move here. Indy has already lost out to Boston and Charlotte on major projects Lilly moved out of state. Lilly”s CEO already addressed the business community on pressing law makers to pass more aggressive laws on better education and lower healthcare cost. The low cost of living and low taxes is an old over exaggerated talking point that Indiana can’t keep using because a lot of other states boast the something. He laid out what Indiana needs to positions itself to compete against other states and future growth.

    3. I think what Lilly really wants are more incentives and using those talking points as cover.

  1. If approved, this drug would both lift Lilly, and also sink the supplement market thst preys on people’s desire to lose weight. A win win especially for the patient

  2. I am nearing age 70, have no thyroid (surgically removed) and lost 75 pounds by eating less and moving a little more. Some 40+ during COVID lockdown. No silver bullet drugs needed, just an oncologist telling me it will help to avoid recurrence of cancer. Just do it!

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In